Catalyst Pharmaceutical Partners and BioMarin Pharmaceutical Enter Into

Catalyst Pharmaceutical Partners and BioMarin Pharmaceutical Enter Into

Filed under: Cocaine Addiction Recovery Statistics

Catalyst has two products in development and is currently evaluating its lead product candidate, CPP-109 (vigabatrin, a GABA aminotransferase inhibitor), for the treatment of cocaine addiction and Tourette's Disorder. CPP-109 has been granted "Fast …
Read more on NASDAQ

 

5000 grant will be used to educate youths about dangers of marijuana

Filed under: Cocaine Addiction Recovery Statistics

Although national statistics show that the overall rate of alcohol and drug use among youths ages 12-20 have declined a bit since 2002, some illicit drug use, such as marijuana, is still prevalent, said Brad Stone, spokesman for the Substance Abuse and …
Read more on Greenville News